Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic Modeling. Jacobs M, Grégoire N, Couet W, Bulitta JB. PLoS Comput Biol. 2016 Mar 11;12(3):e1004782. doi: 10.1371/journal.pcbi.1004782. eCollection 2016 Mar.

Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats. 4. Aztreonam. Marchand S, Grégoire N, Brillault J, Lamarche I, Gobin P, Couet W. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3196-8. doi: 10.1128/AAC.00165-16. Print 2016 May.

Population pharmacokinetics of colistin methanesulphonate (CMS) and colistin in critically ill patients with acute renal failure requiring intermittent haemodialysis. Jacobs M, Grégoire N, Mégarbane B, Gobin P, Balayn D, Marchand S, Mimoz O, Couet W. Antimicrob Agents Chemother. 2016 Jan 4. pii: AAC.01868-15. [Epub ahead of print]

Ciprofloxacin-Loaded Inorganic-Organic Composite Microparticles To Treat Bacterial Lung Infection. Tewes F, Brillault J, Lamy B, O’Connell P, Olivier JC, Couet W, Healy AM. Mol Pharm. 2016 Jan 4;13(1):100-12. doi: 10.1021/acs.molpharmaceut.5b00543. Epub 2015 Dec 19.

Amorphous Calcium Carbonate Based-Microparticles for Peptide Pulmonary Delivery. Tewes F, Gobbo OL, Ehrhardt C, Healy AM. ACS Appl Mater Interfaces. 2016 Jan 20;8(2):1164-75. doi: 10.1021/acsami.5b09023. Epub 2016 Jan 5.


Menu principal

Haut de page